link to RWJMS home pagelink to RWJMS home page
CINJ home page link
WELCOME TO
The Cancer Institute of New Jersey    
 

Request an
Appointment more


The Cancer Institute of New JerseyAs one of the nation's 40 National Cancer Institute-designated Comprehensive Cancer Centers and the only one in New Jersey, The Cancer Institute of New Jersey (CINJ) delivers advanced comprehensive care to adults and children, and conducts cutting-edge cancer research. Our researchers and physicians transform discoveries into clinical practice and provide education and outreach regarding cancer prevention, detection and treatment.

Through our Network of hospitals, the reach of CINJ is statewide providing the best cancer care and the most advanced treatment options through-out the state, quite literally bringing research to life across New Jersey, the nation and beyond.

  • Healthy Male Volunteers Needed for Selenium Study
    CINJ researchers are studying the effects of the mineral selenium in reducing one's risk for prostate cancer. At focus are selenium yeast or selenomethionine and whether they have a role in lowering prostate-specific antigen (PSA) levels and preventing other markers related to the development of prostate cancer in healthy men of different ages. Participants will be asked to take over-the-counter selenium supplements or a placebo for twelve months.Learn more about this prostate cancer clinical trial. more
  • Clinical Trial Studies Combination of ALS and Kidney Cancer Drugs for Melanoma Use
    Research is underway that aims to determine safe dosing levels for the drugs known as riluzole and sorafenib when used together in the treatment of patients with melanoma. CINJ studies of riluzole, approved by the U.S. Food and Drug Administration (FDA) for the treatment of Lou Gehrig's disease, have shown evidence of tumor shrinkage in melanoma patients. Sorafenib, an FDA-approved drug used to treat kidney cancer and a form of liver cancer, is considered a "targeted therapy" that has been shown to slow the spread of cancer cells.
    Learn more about this melanoma cancer clinical trial. more



The Cancer Institute of New Jersey
A National Cancer Institute-designated Comprehensive Cancer Center

195 Little Albany Street, New Brunswick, NJ 08903-2681
732-235-CINJ (2465)

The information contained in this website is not a substitute for medical consultation.
A physician should always be consulted for any health problem or medical condition.
CINJ News

 

CINJ Director Participates in Press Conference

CINJ Director Participates in Press Conference on New Oral-Chemotherapy Drug Law. See more


Direct Injection Vaccine Treatment
for Pancreas Cancer Associated with
Stable Disease

Learn More more

Arthritis and Cholesterol Drugs Well Tolerated in Treatment of Recurrent Prostate Cancer

Learn More more

Century for the Cure Bike Ride Raises Record Breaking $200,000 for CINJ

Learn More more

MORE NEWS more

Broadcasts

Listen to:
CINJ's Cancer Education Series on
EBC Radio
View Our Videos:
"What Does a Minute Hold at CINJ?"

"Spectrum of Hope"
Publications
CINJ's Monthly E-Newsletter more